PDX1 and pancreatic neoplasm: This study demonstrates that targeting PDX-1 using a novel RNAi effector platform regulates both excessive hormonal secretion, as well as reduction of tumor volume, in mouse models of pancreatic cancer, insulinoma and islet neoplasia.